Clinical study to analyze the pathogenesis of systemic lupus erythematosus by multi-faceted approach

Clinical study to analyze the pathogenesis of systemic lupus erythematosus by multi-faceted approach - Clinical study to analyze the pathogenesis of systemic lupus erythematosus

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025538

Enrollment

150

Registered

2017-01-06

Start date

2012-02-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythematosus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients of SLE, connective tissue disease including Sjogren syndrome, systemic sclerosis, vasculitis syndrome and rapid progressive glomerulonephritis are enrolled to this study.

Exclusion criteria

Exclusion criteria: The patient who dis not agree to this study was excluded.

Design outcomes

Primary

Measure	Time frame
1) patient background a)patient ID b)patient height, weight c)therapeutic regimen 2)Clinical findings and data investigating the following data every year a) blood pressure b) urine: proteinuria, Cr, RBC count, urine volume c)renal function:Ccr, BUN, Cr, eGFR d)Hematological study: RBC, Hb, Ht, WBC, PLT e)biochemistry,immunological test:TP, Alb, T-chol, TG, LDL-C, IgA, IgM, IgG, C3, C4, AST, UA, anti-double strand(ds)DNA antibodies, CH50, anti-C1q immune complex, anti-nuclear antibodies f)kidney histological findings g)radio graphic image:CT, MRI, ultrasound, PWV(Pulse Wave Velocity),electroencephalogram, SPECT h)cerebrospinal fluid:cytokine, cell number, pressure, protein, glucose i)other:pleural effusion, ascites, biopsy sample	—

Measure

Time frame

1) patient background a)patient ID b)patient height, weight c)therapeutic regimen 2)Clinical findings and data investigating the following data every year a) blood pressure b) urine: proteinuria, Cr, RBC count, urine volume c)renal function:Ccr, BUN, Cr, eGFR d)Hematological study: RBC, Hb, Ht, WBC, PLT e)biochemistry,immunological test:TP, Alb, T-chol, TG, LDL-C, IgA, IgM, IgG, C3, C4, AST, UA, anti-double strand(ds)DNA antibodies, CH50, anti-C1q immune complex, anti-nuclear antibodies f)kidney histological findings g)radio graphic image:CT, MRI, ultrasound, PWV(Pulse Wave Velocity),electroencephalogram, SPECT h)cerebrospinal fluid:cytokine, cell number, pressure, protein, glucose i)other:pleural effusion, ascites, biopsy sample

—

Secondary

Measure	Time frame
investigating every year	—

Countries

Japan

Contacts

Public ContactKunihiro Ichinose

Nagasaki University Graduate School of Biomedical Sciences Department of Immunology and Rheumatology, Unit of Advanced Preventive Medical Sciences

kichinos@nagasaki-u.ac.jp095-819-7262

Outcome results